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a  b  s  t  r  a  c  t
INTRODUCTION:  Clostridium  difficile  is one  of  the  most  common  healthcare-associated  infections.  Pseu-
domembranous  colitis  is  a serious  complication  of  Clostridium  difficile  infection  (CDI)  after  septic  surgery
and  antibacterial  therapy.  A  sudden  white  blood  cell  (WBC)  count  increase  and  extremely  high leucocy-
tosis  may  be  a predictor  of  a poor  outcome.
PRESENTATION  OF  CASE:  A  77  years  old male  was hospitalised  because  of  lower  leg osteomyelitis  and
was  operated.  He received  antibacterial  treatment  with  Cefazolin  for  three  days  and  then  developed  a
high WBC  count.  The  course  of  the  disease  was  fulminant,  with  a  rapid  increase  in  the  WBC  count  up  to
132,000/mm3 and a septic  shock,  and  required  cardiovascular  and  ventilatory  support.  The  patient  was
started  on  intravenous  Metronidazole  (500  mg  every  eight  hours)  and  oral  Vancomycin  (500  mg  every
six hours).  The  patient’s  condition  gradually  improved  over  a period  of  six  days.  Then  a  hyperthermia
above  39  degrees  Celsius,  hypotension  and  painful  abdominal  bloating  developed,  and  the  WBC  count
peaked  to 186,000/mm3. The  blood  cultures  were  positive  for Klebsiella  pneumoniae. The  patient  died.
DISCUSSION:  In  our case,  we describe  a community-onset,  healthcare-facility-associated,  severe  CDI com-
plicated by  a blood  stream  infection.  The  administration  of  oral  Vancomycin,  which  is highly  active
against  the  intestinal  flora,  could  have  been  responsible  for the  persistence  and  overgrowth  of  Klebsiella
pneumoniae.
CONCLUSIONS:  Severe  CDIs  after  orthopaedic  surgery  and  antibacterial  treatment  complicated  by  the
development  of  nosocomial  infection  significantly  worsen  the prognosis  of  the  disease.  Careful  consid-
eration  of  antibacterial  therapy  and  early  symptom  recognition  may  help  prevent  catastrophic  events.
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1. Introduction
Clostridium difficile infection (CDI) is one of the most com-
mon healthcare-associated infections, with high morbidity and
mortality rates. Clostridium difficile is a spore-forming, anaero-
bic, Gram-positive bacterium. Clostridium difficile toxins can cause
severe complications, including non-stopping diarrhoea, pseu-
domembranous colitis (PMC), toxic megacolon, perforations of the
colon and sepsis [1–4].
A sudden increase in white blood cell (WBC) count coinciding
in asymptomatic patients who receive antibacterial therapy after
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eptic surgery may  be a predictor of Clostridium difficile-associated
iarrhoea, while extremely high leucocytosis may be a predictor of
 poor outcome [5].
Meta-analyses suggest that exposure to several antibiotic cat-
gories, including clindamycin, fluoroquinolones, cephalosporins,
enicillins, macrolides and sulphonamides/trimethoprim, is asso-
iated with an increased risk of CDI in adults [5].
Severe CDIs are often complicated by the development of noso-
omial bloodstream infections (BSIs) that significantly worsen the
rognosis of the disease. Candida or enteric bacteria for the most
art cause BSIs, and the mortality rate associated with this infection
s very high – up to 50 % [6–10].
The aim of this paper is to report a fatal case of orthopaedic
urgery complicated by Clostridium difficile infection and blood-
tream Klebsiella pneumoniae infection.
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
nicalKey.com by Elsevier on April 14, 
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The case report was written according to SCARE guidelines
[11,12].
2. Presentation of case
A 77 years old male with a medical history of hypertension,
atherosclerosis, ischaemic attacks and chronic kidney disease was
admitted at the ICU because of an altered mental state and cardio-
vascular collapse. The patient was afebrile and stuporous, with a
pulse rate of 110 bpm and white blood cell count of 100,440/mm3.
The level of haemoglobin was 73 g/L and of C-reactive protein –
251 mg/L. Urinalysis was unremarkable.
The patient was hospitalised six days earlier due to left tibia
chronic osteomyelitis that had developed after osteosynthesis with
a locked intramedullary nail seven years ago. The patient presented
with stable infected pseudarthrosis, bone resorption around the
nail and locking screws, abscess in soft tissue and a healed fibula
fracture. The patient has not had any surgical treatment due to
infection before, except abscess incision. He had not been tak-
ing any prescription antimicrobial agents at home. Two days after
admission the patient was operated. Under general anaesthesia
in supine position, using a tourniquet on the thigh, the follow-
ing steps were performed: wound revision, implant removal, bone
channel reaming, rinsing and antibiotic-loaded cement nail and
spacer implantation. Surgery was performed by a trauma surgeon
specialising in bone and joint infections. Analyses from the bone
infection site revealed Methicillin-sensitive Staphylococcus aureus.
The patient received antibacterial therapy with Cefazolin 1 g every
six hours for three days after the surgery and then suddenly devel-
oped an elevated WBC  count of up to 54,000/mm3 without any
concomitant symptoms.
The course of the disease was fulminant, with a rapid increase in
the WBC  count up to 133,420/mm3 and a septic shock. Oro-tracheal
intubation and fluid resuscitation were performed, followed by
intravenous norepinephrine and cardiovascular and ventilatory
support. Flow cytometry was done for the purpose of differential
diagnosis, to exclude a malignant haematological disease. Blood
culture was negative. Promisingly, a positive Clostridium difficile A
and B toxin test was obtained from stool. The patient was started
on intravenous Metronidazole (500 mg  IV every eight hours) and
oral Vancomycin (500 mg  every six hours).
Following five days of treatment the patient’s condition gradu-
ally improved. Then, suddenly, a hyperthermia above 39 degrees
Celsius, shivering, hypotension and painful abdominal bloating
developed. The WBC  count peaked to 186,230/mm3 (Table 1).
The rapidly developing, unstable haemodynamics required increas-
ing doses of vasopressors. An urgent CT scan was  performed,
and neither open air, nor fluid were found in the abdomen. The
consulting abdominal surgeon refused surgical intervention. The
patient died 20 h after the beginning of the episode concerned.
The microbiological blood cultures collected before death showed
Klebsiella pneumoniae resistant to some antibacterial drugs, such as
cephalosporins.
A post-mortem was done, and the findings were as follows:
Clostridium difficile pseudomembranous colitis, local purulent-
fibrinous peritonitis, septicaemia with local foci (in the heart,
spleen, lungs, kidneys) (Figs. 1–4).
3. DiscussionA prior antibiotic treatment is the most important risk factor
for the development of CDI. The antibiotic treatment disrupts the
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Data on the antibiotic therapy within the previous 30 days as
ell as other risk factors for the multidrug-resistant organisms
ere gathered from the discharge letter and summary from the pre-
ious hospitalisation in other facilities. These data were negative
1–3,14].
We can assume that this patient was  an asymptomatic carrier
ince the previous hospitalisation episodes, despite the fact that the
ast episode was  five years ago [14,15].
Typically at our surgical wards we  start treatment with oral
etronidazole if a patient has unexplained diarrhoea, leucocytosis
nd subfebrile temperature, and we  start empirical treatment with
ntravenous Metronidazole (500 mg  IV every eight hours) and oral
ancomycin (125–500 mg  every six hours) at the Intensive Care
nit when the symptoms worsen [5].
The more rapidly the life-threatening symptoms occur, the more
otivated clinicians become to initiate early and intensive empir-
cal treatment [16].
The recommended treatment for first recognised episodes is
tratified based on the severity (mild to moderate or severe) of CDI
ssessed by WBC  count (above or below 15,000 cells/mm3), serum
reatinine level (1.5 times the pre-morbid level), hypotension or
hock, ileus and megacolon, which are characteristic of a severe,
omplicated (a.k.a. fulminant) CDI [17].
We followed the recommendation for an initial fulminant
pisode with hypotension and shock: Vancomycin 500 mg  four
imes a day via nasogastric tube and Metronidazole 500 mg
very eight hours intravenously. Gastric bypassing was applied
5].
Neutrophils are the first cells recruited to the colon in response
o a CDI, and the neutrophil response is believed to be a determinant
f the severity of the disease. Autopsy showed extremely dense
eukocyte infiltration in tissues.
The production of neutrophil growth factor in the inflamed tis-
ue facilitates the initial migration of neutrophils from the bone
arrow into peripheral circulation and the recruitment of neu-
rophils to the CDI site. Neutrophil-mediated inflammation and
eutrophil activity itself can lead to immune-mediated damage of
ost tissues [18].
The following parameters had the most evidence to support
heir use as markers of risk for mortality in CDI when assessed at or
ear the time of diagnosis: age, most likely with a cut-off between
65 and 75 years; WBC, with a cut-off of >20,000/mm3; serum crea-
inine, possibly with a cut-off of >200 mmol/L; and serum albumin,ost likely with a cut-off of <25 to 35 g/L [17].
The impact of healthcare-associated bloodstream infections
BSIs) in complicating CDIs is huge [10]. The alterations occurring
nicalKey.com by Elsevier on April 14, 
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2  116,580 223.9 1.5 274 20
3  83,870 125.4 2.3 21.8 219 27
4  59,260 150.7 Low 162 38
5  55,290 131.5 1.2 21.8 132 48
6  70,560 69.4 118 55
7  63,890 28.4 23.4 86 79
8  186,230 80.3 Kl. pneumoniae 3.0 131 48 12
Fig. 2. Representative photomicrographs demonstrate extensive neutrophil infiltration in the lung tissue and blood vessels. The haematoxylin-eosin staining method,
magnification ×100 (A), magnification ×200 (B).
Fig. 3. Representative photomicrographs demonstrate: (A) the myocardial tissue with extensive neutrophil infiltration among cardiomyocytes and in blood vessels; (B)
extensive neutrophil infiltration in the kidney tissue, mostly among the tubules and in small blood vessels. The haematoxylin-eosin staining method, magnification x 100.
filtrat
 methFig. 4. Representative photomicrographs demonstrate: (A) extensive neutrophil in
the  pulmonary artery lumen, magnification x 200. The haematoxylin-eosin stainingin the intestinal flora, which represents a microbiome, can pro-
mote the translocation of pathogens into the blood stream and the
development of nosocomial BSIs. The most common aetiology is the
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In the case presented here the administration of oral Van-
omycin, which is highly active against the intestinal flora, could
nicalKey.com by Elsevier on April 14, 
2021. Elsevier Inc. All rights reserved.
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have been responsible for the persistence and overgrowth of Kleb-
siella pneumoniae in the gastrointestinal tract.
4. Conclusions
We  can assume that extremely high leucocytosis was a factor
for unfavourable prognosis. The gut inflammatory injury caused by
the severe CDI may  be considered as the “second hit,” allowing the
bacterial translocation and BSI. Careful consideration of antibac-
terial therapy and early symptom recognition may  help prevent
catastrophic events.
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